Retatrutide 5mg - (10x Quantity) Bulk Deal

💡 Bulk Order Discount Available

Orders of more than one vial are eligible for discounted pricing. For bulk inquiries or multi-unit research orders, please contact us at Support@peptidesoflondon.com.

🧪 Retatrutide 5mg – Ultra-Pure Research Peptide | ≥99% Purity | Lyophilized Powder

Also known as:

• LY3437943
• Retatrutide Acetate
• CAS Number: [Research Ongoing]
• Molecular Formula: C₂₂₃H₃₄₀N₆₄O₆₉
• Molecular Weight: ~4962.5 g/mol

🔬

Description:

Retatrutide is a next-generation synthetic peptide garnering growing attention in the fields of metabolic and endocrine research. As a triple-receptor agonist, it engages GLP-1R (Glucagon-Like Peptide-1 receptor), GIPR (Gastric Inhibitory Polypeptide receptor), and GCGR (Glucagon receptor) — a rare mechanism that makes it a standout compound in advanced peptide research focused on energy balance, fat metabolism, and caloric signaling.

*In a 48-week randomized study published in 2023, test subjects receiving 12mg of Retatrutide demonstrated an average reduction in total body weight of up to 25.9%, with 86% liver fat reduction, and over 90% achieving normalized liver fat levels — highlighting its profound relevance in metabolic regulation and fat storage studies.*¹

Preclinical models have also shown significant effects on body composition, adipose tissue signaling, and thermogenic response, making Retatrutide a valuable tool for fat oxidation and weight modulation research models.

✅ Key Features:

• ≥99% purity confirmed via HPLC & Mass Spectrometry
• Synthesized in ISO & cGMP-compliant laboratories
• Supplied as sterile, lyophilized powder for maximum shelf stability
• Ideal for non-human metabolic, endocrine, and lipolytic pathway research
• Cold chain shipped to preserve molecular integrity

Storage & Handling

• Store at -20°C for long-term preservation
• Once reconstituted, refrigerate between 2–8°C
• Avoid repeated freeze-thaw cycles
• Protect from light and moisture

Packaged For:

• Academic institutions
• Biotech and pharmacological R&D
• Independent laboratory use
• In vitro and in vivo research under authorized conditions

⚠️

Disclaimer:

This product is strictly intended for laboratory research use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes.

🔗

Reference:

¹ Data sourced from published research in Nature Medicine (2023):

Retatrutide Clinical Study – Nature Journal